Sanofi to acquire Protein Sciences
– Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio – Jul 11, 2017 Paris, France – July 11, 2017 – Sanofi announced today it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut in the United States. Under the terms of the agreement, Sanofi will make an upfront payment of $650 million... Read more